Hydroxycinnamic acids and flavonoids are dietary phenolic antioxidants that are abundant in our diet. Hydroxycinnamic acids are highly sulfated in vivo, and sulfotransferases 
Introduction
In humans, the first-pass metabolism of hydroxycinnamic acids plays a major role in limiting their bioavailability. Human studies and in vitro mechanistic studies showed that hydroxycinnamic acids are predominantly sulfated in the intestine and liver [1] [2] [3] [4] [5] [6] .
Characterization with recombinant human SULTs demonstrated that SULT1A1 and SULT1E1 are the major isoforms involved in the sulfation of hydroxycinnamic acids [4] . SULT1A1, highly expressed in both human liver and intestine, is the most active in the sulfation of all the major hydroxycinnamic acids found in the diet. SULT1E1 catalyzes the sulfation of the 4-hydroxyl groups of ferulic and dihydroferulic acids. Therefore, inhibition of SULTs may be a possible strategy to increase the proportion of unconjugated hydroxycinnamic acids, which, in turn, could lead to a modified or even enhanced bioefficacy [7] .
Flavonoids are natural inhibitors of SULTs. Quercetin, the most abundant flavonol in foods, is a potent inhibitor of SULT1A1 with IC 50 value of <100 nM [8] [9] [10] . Flavonoids from different subgroups including flavones, flavonols, flavanone and isoflavones also show highly effective inhibition of SULTs, especially SULT1A1. Given the importance of SULT1A1 in the sulfation of hydroxycinnamic acids, the concomitant consumption of flavonoids and hydroxycinnamic acids may inhibit the metabolism of the latter. In particular, human intestinal SULTs may be inhibited by dietary doses of flavonoids, since the local concentrations of flavonoids in the gut is much higher than that in plasma [11] . Human liver is another important 5 site of hydroxycinnamic acid sulfation. However, flavonoids are extensively metabolized in vivo into conjugates that are present in much lower concentrations in the circulation (<10 µM).
It is thus critical to evaluate the inhibitory effect, if any, of the biologically relevant flavonoid conjugates on the sulfation of hydroxycinnamic acids.
In this study, we investigated the inhibitory effects of flavonoids and their conjugates on the sulfation of five major dietary hydroxycinnamic acids (caffeic acid, dihydrocaffeic acid, dihydroferulic acid, ferulic acid and isoferulic acids) using human intestine and liver homogenates. Furthermore, we examined the inhibitory effect of luteolin, quercetin and quercetin conjugates (gluucronides and sulfate) on hydroxycinnamic acid sulfation in the human hepatoma cell line, HepG2, as a model for human liver metabolism.
Methods and materials

Chemicals
Caffeic acid, ferulic acid, isoferulic acid, quercetin, (+)-catechin and (-)-epicatechin were purchased from Sigma-Aldrich (St. Louis, MO). Apigenin, daidzein, eriodictyol, genistein, hesperetin, kaempferol, isorhamnetin, luteolin and phloretin were obtained from Extrasynthèse, (Genay, France). Dihydrocaffeic acid and dihydroferulic acid were purchased acid-3-O-glucuronide, isoferulic acid-3-O-sulfate were synthesized as described elsewhere [12] and kindly provided by Prof Denis Barron, Nestle Research Center, Lausanne, Switzerland. Quercetin-7-O-glucuronide and quercetin-3-O-glucuronide were synthesized enzymatically and purified by HPLC [13, 14] ; quercetin-3′-O-sulfate was chemically synthesized as described [15, 16] . Identity of the compounds was further confirmed by comparing the retention time and absorption spectra of the authentic standards kindly provided by Dr. Paul Kroon and Dr Paul Needs. The purities were checked by HPLC to be over 95 %.
3'-phosphoadenosine-5'-phosphosulfate (PAPS) was from MP Biochemicals (London, UK).
Pooled Liver S9 homogenate was purchased from Sigma-Aldrich, while pooled intestinal (duodenum/jejunum) S9 homogenate was from Xenotech (Lenexa, Kansas). All other chemicals, unless otherwise stated, were purchased from Sigma-Aldrich.
Inhibition of hydroxycinnamic acid sulfation by flavonoids in human liver and intestinal
S9
The incubation mixture, in a final volume of 50 μL, consisted of 100 mM potassium phosphate buffer (pH 7.4), with 100 µM vitamin C, 100 µM PAPS and 1 mM DTT. Human Quantification was based on the peak area at 370 nm.
Data analysis
Data are shown as mean ± S.D. Statistical differences were determined using analysis of variance using the student's t-test. Differences were considered significant when p<0.05.
Results
Inhibition of hydroxycinnamic acid sulfation by flavonoids in human intestinal S9
The inhibitory effect of 11 flavonoids on hydroxycinnamic acid sulfation was evaluated using human intestinal S9; caffeic acid and ferulic acid were chosen as representative substrates for SULT1A1 and SULT1E1, respectively. It was found that flavonoids inhibited the sulfation of caffeic acid and ferulic acid in a concentration-dependant manner. respectively. Other good inhibitors included the flavones apigenin and luteolin, as well as phloretin, but for the flavanols, catechin and epicatechin, the inhibitory effect was relatively moderate. The inhibitory effect of isoflavones genistein and daidzein on dihydrocaffeic acid, dihydroferulic acid and isoferulic acid sulfation was further examined (Figure 1 ). Isoflavones were found to be potent inhibitors of caffeic and dihydrocaffeic acid sulfation, while they are less effective in inhibiting sulfation of methylated forms, in particular dihydroferulic acid.
Inhibition of hydroxycinnamic acid sulfation by flavonoids in human liver S9
Sulfation of caffeic acid and ferulic acid in liver S9 was more sensitive to inhibition by flavonoids. Inhibitory activities of the flavonoids are shown in Table 2 . The most potent inhibitors were luteolin and quercetin. Luteolin, in particular, was found to strongly inhibit quercetin-3′-O-sulfate [22] , the rate of conversion is very low (<10 % after 48 h). Thus, the contribution of formed quercetin-3′-O-sulfate to cellular uptake and SULT-inhibitory effect of quercetin glucuronides is expected to be minimal over 4 h.
Discussion
SULTs are important determinants of the bioavailability and bioactivity of hydroxycinnamic acids in humans. On the other hand, dietary flavonoids are natural inhibitors of SULTs. Here, using human S9 homogenates, recombinant human SULT1A1 and HepG2 cells, we demonstrated that flavonoids are potent inhibitors of hydroxycinnamic acid sulfation.
In the intestinal S9 homogenates, all the flavonoids tested significantly inhibited sulfation of hydroxycinnamic acids, with the isoflavones daidzein and genistein being the most potent inhibitors (Table 1 ). In the human small intestine, SULT1A1 and SULT1A3 are highly expressed and they are both highly active in the conjugation of hydroxycinnamic acids [4] . Of the two isozymes, SULT1A3 activity is known to be relatively resistant to inhibition by flavonoids [17] . Hence, SULT1A3-mediated sulfation may explain the reduced inhibitory effect of flavonoids in the intestinal S9 compared to the liver S9.
Nevertheless, local concentrations of flavonoids in the gut lumen are potentially much higher than that in the human plasma, and thus dietary flavonoids may exert inhibitory activity to intestinal SULTs without being absorbed into circulation. It has been estimated that 500 mg of polyphenols diluted in the digestive bolus would result in concentrations up to 3 mM in the lumen. Daily consumption of total flavonoids varies between individuals, but can easily reach more than 1 g [11] . Factoring in the significant transfer of different flavonoids (40-60 %) into the intestinal wall as shown by several ileostomy studies [18] [19] [20] , dietary intake of flavonoids will result in levels in the intestinal epithelial cells sufficiently high to potently inhibit both SULT1A1 and SULT1A3 activity. In our previous study, we showed that intestinal SULTs contribute, at least in part, to sulfation of hydroxycinnamic acids in vivo [4] and it may represent a significant site of metabolic interaction between dietary flavonoids and hydroxycinnamic acids.
The liver is an important site of hydroxycinnamic acid metabolism in humans. In vitro incubations with liver S9 ( Table 2 ) homogenates showed that human liver SULTs were more susceptible to inhibition compared to the intestine, with IC 50 values in nanomolar range for flavones (luteolin, apigenin), flavonols (quercetin) and isoflavones (daidzein and genistein).
This is in good agreement with several studies which showed flavonoids are potent inhibitors of SULTs in human liver homogenates, in particular SULT1A1 [8, 17] . Strong inhibition of caffeic acid and ferulic acid sulfation was also observed with both luteolin and quercetin in However, circulating levels of flavonoids are much lower than that in the gut, reaching a maximum of 4 µM in the plasma depending on the dose and the type of flavonoids ingested [21, 11] . Moreover, flavonoids such as quercetin are highly metabolized in the intestine and are conjugated before reaching the liver [22] . Here, we demonstrate that glucuronide and sulfate conjugates of quercetin also significant inhibited sulfation in human liver S9, with IC 50 values in the low micromolar range. In HepG2 cells, quercetin-3′-O-sulfate showed inhibitory activity, while the glucuronides had no effect (Figure 4) . Quercetin conjugates may act as direct inhibitors of SULTs. Quercetin glucuronides and sulfates can also be hydrolyzed by β-glucuronidase and sulfatase, respectively, to release the highly potent inhibitor quercetin, which in turn significantly inhibits SULTs-mediated sulfation of hydroxycinnamic acids.
However, given the low sulfatase activity in HepG2 cells [22] , it is likely that quercetin -3′-O-sulfate act predominantly as a direct inhibitor of SULTs in these cells.
]The lack of inhibitory activity of quercetin glucuronides could be attributed to their low cellular uptake compared to quercetin-3′-O-sulfate ( Figure 3 ). Of note, the human liver express an array of uptake transporters that are repressed in the HepG2 cells lines, which may contribute to an enhanced accumulation of flavonoid conjugates in liver [23] . Hence, the inhibitory activities of these quercetin conjugates could be greater in the liver in vivo. The elimination half lives of quercetin metabolites in human studies were in the range of [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] hours. The relatively long half-lives of the quercetin conjugates imply that consumption of quercetin-rich foods can potentially inhibit hydroxycinnamic acid metabolism in vivo over a significant period of time (~1 day) [24] .
This study highlights the potential of flavonoids in modulating the metabolism of hydroxycinnamic acids via the inhibition of SULTs ( Figure 5 ). In humans, hydroxycinnamic 
